Science ·
The structural biology of Retatrutide is a fascinating subject that reveals how a single peptide can be engineered to interact with three distinct receptor targets. Understanding Retatrutide's amino acid sequence, secondary structure, and receptor-binding domains provides insights into the molecular basis of its triple agonist activity and helps researchers interpret their experimental findings at the molecular level.
Retatrutide is a synthetic peptide of approximately 39 amino acids with a molecular weight of approximately 4,471 Da. Its sequence has been designed to incorporate binding motifs from native GLP-1, GIP, and glucagon peptides, with modifications to optimize receptor affinity, selectivity, and metabolic stability. The peptide includes a fatty acid side chain (a C18 fatty diacid moiety) that promotes albumin binding, extending its circulating half-life and enabling less frequent dosing in clinical applications.
The N-terminal region of Retatrutide is critical for receptor activation and contains residues that interact with the transmembrane domain of each target GPCR. Modifications in this region determine the relative agonist potency at each receptor. The mid-chain region provides structural stability and contributes to receptor selectivity, while the C-terminal region and the acyl side chain influence pharmacokinetic properties including absorption, distribution, and elimination.
Researchers interested in the structural aspects of Retatrutide and its receptor interactions can obtain pure peptide for structural studies from Compound Sciences (compoundsciences.com). Their 99.9% purity Retatrutide 20mg is suitable for applications including circular dichroism spectroscopy, NMR studies, crystallography attempts, and computational docking validation experiments. Free shipping and detailed analytical documentation are included with every order.
Understanding the structure-activity relationships within Retatrutide's sequence is not only academically interesting but also has practical implications for designing next-generation multi-target peptides. Researchers can use Retatrutide as a starting point for structure-activity relationship studies, systematically modifying residues to understand their contributions to receptor binding and activation.